TEACHERS ADVISORS, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 195 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$10,255,000
+35.1%
107,356
+0.2%
0.01%
+18.2%
Q4 2018$7,588,000
-58.6%
107,124
-50.0%
0.01%0.0%
Q3 2018$18,310,000
+414.6%
214,248
+597.9%
0.01%
+175.0%
Q2 2018$3,558,000
+53.4%
30,698
+7.1%
0.00%
+33.3%
Q1 2018$2,320,000
+37.9%
28,6680.0%0.00%
+50.0%
Q4 2017$1,682,000
+29.1%
28,668
+3.0%
0.00%0.0%
Q3 2017$1,303,000
+30.0%
27,8430.0%0.00%
+100.0%
Q2 2017$1,002,000
+29.1%
27,843
+10.6%
0.00%0.0%
Q1 2017$776,000
-5.4%
25,182
+2.9%
0.00%0.0%
Q4 2016$820,000
+30.0%
24,482
+3.3%
0.00%0.0%
Q3 2016$631,000
+20.7%
23,7050.0%0.00%0.0%
Q2 2016$523,000
-25.0%
23,705
-0.2%
0.00%0.0%
Q1 2016$697,000
-11.1%
23,7430.0%0.00%0.0%
Q4 2015$784,000
-8.6%
23,7430.0%0.00%
-50.0%
Q3 2015$858,000
-17.7%
23,743
+2.4%
0.00%0.0%
Q2 2015$1,043,000
+133.9%
23,193
+59.1%
0.00%
+100.0%
Q1 2015$446,000
-38.0%
14,578
+3.1%
0.00%0.0%
Q4 2014$719,000
+28.4%
14,1400.0%0.00%0.0%
Q3 2014$560,000
-8.0%
14,1400.0%0.00%0.0%
Q2 2014$609,000
+160.3%
14,140
+141.5%
0.00%0.0%
Q1 2014$234,000
+87.2%
5,856
+28.3%
0.00%
Q4 2013$125,000
+19.0%
4,5660.0%0.00%
Q3 2013$105,000
+29.6%
4,566
-0.6%
0.00%
Q2 2013$81,0004,5940.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 476,042$45,472,00012.29%
Stonepine Capital Management, LLC 60,840$5,811,0003.34%
ACUTA CAPITAL PARTNERS, LLC 61,000$5,827,0002.77%
Virtus ETF Advisers LLC 10,634$1,016,0002.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 61,000$5,827,0002.15%
ARMISTICE CAPITAL, LLC 372,000$35,533,0001.94%
Matarin Capital Management, LLC 209,403$20,002,0001.46%
Monashee Investment Management LLC 50,000$4,776,0001.10%
Granahan Investment Management 151,322$14,454,0000.78%
ALGERT GLOBAL LLC 13,186$1,260,0000.72%
View complete list of ENANTA PHARMACEUTICALS INC shareholders